How many employees does Madrigal Pharmaceuticals, Inc. have?

Madrigal Pharmaceuticals, Inc. reported 915 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 19, 2026. That is up 73.3% from a year earlier.

What is Madrigal Pharmaceuticals, Inc.'s revenue per employee?

Madrigal Pharmaceuticals, Inc. brought in $958M of revenue in fiscal Dec 2025, which is $1.05M per employee. That ranks 13 of 39 companies we track in Biotechnology, where the median is $602K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Madrigal Pharmaceuticals, Inc. employees and revenue per employee

MDGL · Biotechnology · $11.5B market cap

Madrigal Pharmaceuticals, Inc. had 915 employees at the end of fiscal Dec 2025, up 73.3% from a year earlier. Revenue for the year was $958M, up 432.1% from a year earlier, or $1.05M per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

915

+73.3% YoY

Revenue

$958M

+432.1% YoY

Revenue / employee

$1.05M

Peer median $602K

Rank in industry

13 of 39

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2024

Hover a year for the numbers.

MDGL employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2025	915	$958M	$1.05M	+73.3%	+432.1%
Dec 2024	528	$180M	$341K	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Madrigal Pharmaceuticals, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
HALO Halozyme Therapeutics, Inc.	423	$1.40B	$3.30M	Efficient growth
BCRX BioCryst Pharmaceuticals, Inc.	435	$875M	$2.01M	Leaner
ARWR Arrowhead Pharmaceuticals, Inc.	711	$829M	$1.17M	Efficient growth
MDGL Madrigal Pharmaceuticals, Inc.	915	$958M	$1.05M	Efficient growth
AXSM Axsome Therapeutics, Inc.	925	$638M	$690K	Efficient growth
IONS Ionis Pharmaceuticals, Inc.	1,402	$944M	$673K	Efficient growth
TXG 10x Genomics, Inc.	1,178	$643M	$546K	Leaner
TECH Bio-Techne Corporation	3,000	$1.22B	$405K	Contracting
LEGN Legend Biotech Corporation	2,900	$1.03B	$355K	Efficient growth

Every Healthcare company

Questions about Madrigal Pharmaceuticals, Inc.

How many employees does Madrigal Pharmaceuticals, Inc. have?: Madrigal Pharmaceuticals, Inc. reported 915 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 19, 2026. That is up 73.3% from a year earlier.
What is Madrigal Pharmaceuticals, Inc.'s revenue per employee?: Madrigal Pharmaceuticals, Inc. brought in $958M of revenue in fiscal Dec 2025, which is $1.05M per employee. That ranks 13 of 39 companies we track in Biotechnology, where the median is $602K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare MDGL with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Madrigal Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 19, 2026. This is data, not a recommendation to buy or sell MDGL.